Abrilumab targets both Human ITGA4 and ITGB7.Abrilumab has been investigated for the treatment of Crohn’s Disease and Ulcerative Colitis.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? *
Did it work in your application? *
Your review *
Save my name, email, and website in this browser for the next time I comment.
Send us a message from the form below
Lab / Company
in 2023, NO price increase on ProteoGenix products, to support your discoveries💥